Whole blood and serum for immunologic assays. 6.2.4 Long Term Follow Up (Every 3 Months ± 7 Days for 6 months) /End of study visit Long term follow up for 6 month ss post the last dose of immunotherapy. End of study visit will be the last long term follow up visit 1. Medical/Clinical assessment including concurrent medications/treatments. 39 Date: 8 April 2016 v 2.1 INO-3112 UPCC # 39313 / Inovio HPV -005 Inovio Pharmaceuticals, Inc Clinical Protocol 2. Complete physical examination including, but not limited to vital signs , weight and oxygen saturation.